FDA APPROVED
FDA-approved, preservative- and bisulfite-free OMIDRIA
™
(phenylephrine
and ketorolac injection) 1% / 0.3% is the only treatment proven to maintain
pupil size and reduce postoperative ocular pain in cataract surgery
Maintains pupil size by preventing intraoperative miosis
Significantly reduces postoperative ocular pain
Contains ketorolac (an NSAID) together with phenylephrine
(a mydriatic agent) and is added to the irrigation solution
INDICATIONS AND USAGE
OMIDRIA is an alpha 1-adrenergic receptor agonist and nonselective
cyclooxygenase inhibitor indicated for:
Maintaining pupil size by preventing intraoperative miosis
Reducing postoperative ocular pain
OMIDRIA is added to an irrigation solution used during
cataract surgery or intraocular lens replacement.
IS THE TIME TO PREVENT INTRAOPERATIVE MIOSIS
Please see the Important Safety Information
on the back of this page.
